$162.03
6.213.99%
Ult. Agg.: Oct 15, 4:25 AM
$165.05
9.235.92%
AstraZeneca (AZN) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $1.52 | $1.53 | $2.18 | $1.14 |
| Actual | $2.63 | $2.58 | $2.12 | $1.19 |
| Surprise | +73.0% | +68.6% | -2.75% | +4.39% |
| Revenue | ||||
| Estimate | $15.43B | $14.93B | $15.58B | $14.81B |
| Actual | $15.38B | $15.29B | $15.50B | $15.19B |
| Surprise | -0.27% | +2.40% | -0.49% | +2.61% |
| Metric | Q3 '26E |
|---|---|
| Earnings Per Share (Non-GAAP) | |
| Consensus | $1.35 |
| Revenue | |
| Consensus | $16.01B |
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 27, 2026 | $2.63 | $1.52 | 73.0 % |
| Q1 | Apr 29, 2026 | $2.58 | $1.53 | 68.6 % |
| Q4 | Feb 10, 2026 | $2.12 | $2.18 | -2.75 % |
| Q3 | Nov 6, 2025 | $1.19 | $1.14 | 4.39 % |
| Trimestre fiscale | Data segnalata | Entrate effettive | Entrate stimate | Sorpresa% |
|---|---|---|---|---|
| Q2 | Jul 27, 2026 | $15.38B | $15.43B | -0.27 % |
| Q1 | Apr 29, 2026 | $15.29B | $14.93B | 2.40 % |
| Q4 | Feb 10, 2026 | $15.50B | $15.58B | -0.49 % |
| Q3 | Nov 6, 2025 | $15.19B | $14.81B | 2.61 % |